| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |